GlassScriptPhysician profile
Jose P Miranda
NPI 1679616437
$5,327.91
in general payments reported to CMS, 2019-2025
16 companies · $1,827 in 2025
The $1,827 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $176 · 2021: $518 · 2022: $696 · 2023: $366 · 2024: $1,501 · 2025: $1,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,693.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,761.34 | 2019-2025 | Nucala, Arexvy |
| Genzyme Corporation | $733.83 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $526.65 | 2023-2025 | Winrevair |
| Regeneron Healthcare Solutions, INC. | $364.17 | 2024-2025 | Dupixent |
| Inspire Medical Systems, INC. | $265.49 | 2024 | Inspire |
| Verona Pharma, INC. | $244.43 | 2025 | Ohtuvayre |
| Janssen Biotech, INC. | $244.39 | 2022-2025 | Carvykti, Rybrevant |
| Baxter Healthcare | $211.90 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Actelion Pharmaceuticals US, INC. | $204.87 | 2019-2022 | |
| United Therapeutics Corporation | $145.10 | 2021-2025 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $123.30 | 2025 | Airsupra |
| Novo Nordisk INC | $121.87 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.23 | 2025 | Ofev |
| Resmed Corp | $96.28 | 2024 | |
| Pfizer INC. | $88.95 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $80.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Miranda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.